0

Platelet Disorders Collection
 1-20 of 179 Articles
Letters |  2 July 2013
Successful Treatment of the Postpartum Atypical Hemolytic Uremic Syndrome With Eculizumab
Stefan Zschiedrich, MD; Eric P. Prager, MD; E. Wolfgang Kuehn, MD
Ann Intern Med. 2013;159(1):76. doi:10.7326/0003-4819-159-1-201307020-00023
Reviews |  2 January 2007
Systematic Review: Efficacy and Safety of Rituximab for Adults with Idiopathic Thrombocytopenic Purpura
Donald M. Arnold, MD, MSc; Francesco Dentali, MD; Mark A. Crowther, MD, MSc; et al.
Ann Intern Med. 2007;146(1):25-33. doi:10.7326/0003-4819-146-1-200701020-00006
Articles |  5 April 2005
Brief Communication: Duration of Platelet Dysfunction after a 7-Day Course of Ibuprofen
Neil A. Goldenberg, MD; Linda Jacobson, MT; Marilyn J. Manco-Johnson, MD
Ann Intern Med. 2005;142(7):506-509. doi:10.7326/0003-4819-142-7-200504050-00009
Reviews |  20 January 2004
Management of Adult Patients with Persistent Idiopathic Thrombocytopenic Purpura Following Splenectomy: A Systematic Review
Sara K. Vesely, PhD; Jedidiah J. Perdue, MPH; Mujahid A. Rizvi, MD, MPH; et al.
Ann Intern Med. 2004;140(2):112-120. doi:10.7326/0003-4819-140-3-200402030-00012
Articles |  16 September 2003
The Rate of Progression to Polycythemia Vera or Essential Thrombocythemia in Patients with Erythrocytosis or Thrombocytosis
Marco Ruggeri, MD; Alberto Tosetto, MD; Maurizio Frezzato, MD; et al.
Ann Intern Med. 2003;139(6):470-475. doi:10.7326/0003-4819-139-6-200309160-00009
Editorials |  21 January 2003
Thrombotic Thrombocytopenic Purpura: From the Bench to the Bedside, but Not Yet to the Community
James N. George, MD; Sara K. Vesely, PhD
Ann Intern Med. 2003;138(2):152-153. doi:10.7326/0003-4819-138-2-200301210-00018
Brief Communications |  21 January 2003
Remission of Chronic Thrombotic Thrombocytopenic Purpura after Treatment with Cyclophosphamide and Rituximab
Xinglong Zheng, MD, PhD; Arnel M. Pallera, MD; Lawrence T. Goodnough, MD; et al.
Ann Intern Med. 2003;138(2):105-108. doi:10.7326/0003-4819-138-2-200301210-00011
Brief Communications |  5 February 2002
Delayed-Onset Heparin-Induced Thrombocytopenia
Lawrence Rice, MD; Walid K. Attisha, MD; Alane Drexler, MS, RN; et al.
Ann Intern Med. 2002;136(3):210-215. doi:10.7326/0003-4819-136-3-200202050-00009
Brief Communications |  18 December 2001
Quinine-Associated Thrombotic Thrombocytopenic Purpura–Hemolytic Uremic Syndrome: Frequency, Clinical Features, and Long-Term Outcomes
Kiarash Kojouri, MD, MPH; Sara K. Vesely, PhD; James N. George, MD
Ann Intern Med. 2001;135(12):1047-1051. doi:10.7326/0003-4819-135-12-200112180-00008
Brief Communications |  2 October 2001
Delayed-Onset Heparin-Induced Thrombocytopenia and Thrombosis
Theodore E. Warkentin, MD; John G. Kelton, MD
Ann Intern Med. 2001;135(7):502-506. doi:10.7326/0003-4819-135-7-200110020-00009
Brief Communications |  15 August 2000
Anti-CD20 Chimeric Monoclonal Antibody Treatment of Refractory Immune-Mediated Thrombocytopenia in a Patient with Chronic Graft-versus-Host Disease
Voravit Ratanatharathorn, MD; Erik Carson, MD; Christopher Reynolds, MD; et al.
Ann Intern Med. 2000;133(4):275-279. doi:10.7326/0003-4819-133-4-200008150-00011
Brief Communications |  16 May 2000
Antibody Inhibitors to von Willebrand Factor Metalloproteinase and Increased Binding of von Willebrand Factor to Platelets in Ticlopidine-Associated Thrombotic Thrombocytopenic Purpura
Han-Mou Tsai, MD; Lawrence Rice, MD; Ravindra Sarode, MD; et al.
Ann Intern Med. 2000;132(10):794-799. doi:10.7326/0003-4819-132-10-200005160-00005
Brief Communications |  7 March 2000
Recombinant Human Thrombopoietin Attenuates Carboplatin-Induced Severe Thrombocytopenia and the Need for Platelet Transfusions in Patients with Gynecologic Cancer
Saroj Vadhan-Raj, MD; Claire F. Verschraegen, MD; Carlos Bueso-Ramos, MD; et al.
Ann Intern Med. 2000;132(5):364-368. doi:10.7326/0003-4819-132-5-200003070-00005
Reviews |  1 December 1998
Drug-Induced Thrombocytopenia: A Systematic Review of Published Case Reports
James N. George, MD; Gary E. Raskob, MSc; Shehla Rizvi Shah, MD; et al.
Ann Intern Med. 1998;129(11_Part_1):886-890. doi:10.7326/0003-4819-129-11_Part_1-199812010-00009
Brief Communications |  1 April 1998
Thrombotic Thrombocytopenic Purpura Associated with Ticlopidine: A Review of 60 Cases
Charles L. Bennett, MD, PhD; Peter D. Weinberg, BS; Karine Rozenberg-Ben-Dror, PharmD; et al.
Ann Intern Med. 1998;128(7):541-544. doi:10.7326/0003-4819-128-7-199804010-00004
Articles |  1 November 1997
The Pathogenesis of Venous Limb Gangrene Associated with Heparin-Induced Thrombocytopenia
Theodore E. Warkentin, MD; Leela J. Elavathil, MBBS; Catherine P.M. Hayward, MD; et al.
Ann Intern Med. 1997;127(9):804-812. doi:10.7326/0003-4819-127-9-199711010-00005
Editorials |  1 May 1997
Thrombopoietin: Platelets on Demand
Kenneth Kaushansky, MD
Ann Intern Med. 1997;126(9):731-733. doi:10.7326/0003-4819-126-9-199705010-00009
Position Papers |  15 February 1997
Diagnosis and Treatment of Idiopathic Thrombocytopenic Purpura: Recommendations of the American Society of Hematology
Ann Intern Med. 1997;126(4):319-326. doi:10.7326/0003-4819-126-4-199702150-00010
Editorials |  15 February 1997
Idiopathic Thrombocytopenic Purpura: Lessons from a Guideline
James N. George, MD; Frank Davidoff, MD, Editor
Ann Intern Med. 1997;126(4):317-318. doi:10.7326/0003-4819-126-4-199702150-00009
Ideas and Opinions |  15 February 1997
Therapy for Adults with Refractory Chronic Immune Thrombocytopenic Purpura
Robert McMillan, MD
Ann Intern Med. 1997;126(4):307-314. doi:10.7326/0003-4819-126-4-199702150-00007
Advertisement
Forgot your password?
Enter your username and email address. We'll send you a reminder to the email address on record.
(Required)
(Required)